• Something wrong with this record ?

Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study

S. McWhinney, M. Kolenic, K. Franke, M. Fialova, P. Knytl, M. Matejka, F. Spaniel, T. Hajek

. 2021 ; 47 (6) : 1772-1781. [pub] 20211021

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22012075

Grant support
142255 CIHR - Canada

E-resources Online Full text

NLK Free Medical Journals from 2006 to 1 year ago
PubMed Central from 2006 to 1 year ago
Europe PubMed Central from 2006 to 1 year ago
Medline Complete (EBSCOhost) from 1996-01-01 to 1 year ago

Links

PubMed 34080013
DOI 10.1093/schbul/sbab064
Knihovny.cz E-resources

BACKGROUND: Obesity is highly prevalent in schizophrenia, with implications for psychiatric prognosis, possibly through links between obesity and brain structure. In this longitudinal study in first episode of psychosis (FEP), we used machine learning and structural magnetic resonance imaging (MRI) to study the impact of psychotic illness and obesity on brain ageing/neuroprogression shortly after illness onset. METHODS: We acquired 2 prospective MRI scans on average 1.61 years apart in 183 FEP and 155 control individuals. We used a machine learning model trained on an independent sample of 504 controls to estimate the individual brain ages of study participants and calculated BrainAGE by subtracting chronological from the estimated brain age. RESULTS: Individuals with FEP had a higher initial BrainAGE than controls (3.39 ± 6.36 vs 1.72 ± 5.56 years; β = 1.68, t(336) = 2.59, P = .01), but similar annual rates of brain ageing over time (1.28 ± 2.40 vs 1.07±1.74 estimated years/actual year; t(333) = 0.93, P = .18). Across both cohorts, greater baseline body mass index (BMI) predicted faster brain ageing (β = 0.08, t(333) = 2.59, P = .01). For each additional BMI point, the brain aged by an additional month per year. Worsening of functioning over time (Global Assessment of Functioning; β = -0.04, t(164) = -2.48, P = .01) and increases especially in negative symptoms on the Positive and Negative Syndrome Scale (β = 0.11, t(175) = 3.11, P = .002) were associated with faster brain ageing in FEP. CONCLUSIONS: Brain alterations in psychosis are manifest already during the first episode and over time get worse in those with worsening clinical outcomes or higher baseline BMI. As baseline BMI predicted faster brain ageing, obesity may represent a modifiable risk factor in FEP that is linked with psychiatric outcomes via effects on brain structure.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012075
003      
CZ-PrNML
005      
20220506130203.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/schbul/sbab064 $2 doi
035    __
$a (PubMed)34080013
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a McWhinney, Sean $u Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
245    10
$a Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study / $c S. McWhinney, M. Kolenic, K. Franke, M. Fialova, P. Knytl, M. Matejka, F. Spaniel, T. Hajek
520    9_
$a BACKGROUND: Obesity is highly prevalent in schizophrenia, with implications for psychiatric prognosis, possibly through links between obesity and brain structure. In this longitudinal study in first episode of psychosis (FEP), we used machine learning and structural magnetic resonance imaging (MRI) to study the impact of psychotic illness and obesity on brain ageing/neuroprogression shortly after illness onset. METHODS: We acquired 2 prospective MRI scans on average 1.61 years apart in 183 FEP and 155 control individuals. We used a machine learning model trained on an independent sample of 504 controls to estimate the individual brain ages of study participants and calculated BrainAGE by subtracting chronological from the estimated brain age. RESULTS: Individuals with FEP had a higher initial BrainAGE than controls (3.39 ± 6.36 vs 1.72 ± 5.56 years; β = 1.68, t(336) = 2.59, P = .01), but similar annual rates of brain ageing over time (1.28 ± 2.40 vs 1.07±1.74 estimated years/actual year; t(333) = 0.93, P = .18). Across both cohorts, greater baseline body mass index (BMI) predicted faster brain ageing (β = 0.08, t(333) = 2.59, P = .01). For each additional BMI point, the brain aged by an additional month per year. Worsening of functioning over time (Global Assessment of Functioning; β = -0.04, t(164) = -2.48, P = .01) and increases especially in negative symptoms on the Positive and Negative Syndrome Scale (β = 0.11, t(175) = 3.11, P = .002) were associated with faster brain ageing in FEP. CONCLUSIONS: Brain alterations in psychosis are manifest already during the first episode and over time get worse in those with worsening clinical outcomes or higher baseline BMI. As baseline BMI predicted faster brain ageing, obesity may represent a modifiable risk factor in FEP that is linked with psychiatric outcomes via effects on brain structure.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a předčasné stárnutí $x diagnostické zobrazování $x etiologie $x patologie $x patofyziologie $7 D019588
650    _2
$a index tělesné hmotnosti $7 D015992
650    12
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a longitudinální studie $7 D008137
650    12
$a strojové učení $7 D000069550
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a obezita $x komplikace $x diagnostické zobrazování $x patologie $x patofyziologie $7 D009765
650    _2
$a psychotické poruchy $x diagnostické zobrazování $x patologie $x patofyziologie $7 D011618
650    _2
$a rizikové faktory $7 D012307
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kolenic, Marian $u National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Franke, Katja $u Structural Brain Mapping Group, Department of Neurology, Jena University Hospital, Jena, Germany
700    1_
$a Fialova, Marketa $u National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Knytl, Pavel $u National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Matejka, Martin $u National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Spaniel, Filip $u National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hajek, Tomas $u Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada $u National Institute of Mental Health, Klecany, Czech Republic $1 https://orcid.org/0000000302818458 $7 mzk2002112973
773    0_
$w MED00004355 $t Schizophrenia bulletin $x 1745-1701 $g Roč. 47, č. 6 (2021), s. 1772-1781
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34080013 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130155 $b ABA008
999    __
$a ok $b bmc $g 1789601 $s 1163276
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 47 $c 6 $d 1772-1781 $e 20211021 $i 1745-1701 $m Schizophrenia bulletin $n Schizophr Bull $x MED00004355
GRA    __
$a 142255 $p CIHR $2 Canada
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Archiving options